Balinsua, April Rose Y.

HRN: 27-68-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2025
CO-AMOXICLAV 625MG (TAB)
09/04/2025
09/11/2025
PO
1 Tab
TID
S/P CS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines